Patents Assigned to Japan Science and Technology Corporation
  • Patent number: 7204263
    Abstract: A method of simply controlling the flow of fluid in a micro system without using a complicated value structure, comprising the steps of adding the substance transformed from sol-gel by stimulation to the fluid flowing through the micro flow passage of the micro system, and adding the stimulation to the fluid at a desired position on the micro flow passage to transform the fluid into gel for flow control.
    Type: Grant
    Filed: November 8, 2001
    Date of Patent: April 17, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Shouichirou Tsukita, Takashi Funatsu, Shuichi Shouji
  • Patent number: 7204984
    Abstract: Anti-acetyllysine monoclonal antibody capable of recognizing N?-acetyllysine regardless of the types of the adjacent amino acids. Namely, a monoclonal antibody having a light chain comprising a constant region having the amino acid sequence represented by SEQ ID NO:1 and a variable region having the amino acid sequence represented by SEQ ID NO:2 or an amino acid sequence derived from this amino acid sequence by deletion, substitution or addition of one to several amino acids, and a heavy chain comprising a constant region having the amino acid sequence represented by SEQ ID NO:3 and a variable region having the amino acid sequence represented by SEQ ID NO:4 or an amino acid sequence derived from this amino acid sequence by deletion, substitution or addition of one to several amino acids, and being capable of recognizing N?-acetyllysine in a protein regardless of the types of the adjacent amino acids, i.e.
    Type: Grant
    Filed: March 13, 2002
    Date of Patent: April 17, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Yasuhiko Komatsu, Minoru Yoshida
  • Patent number: 7202394
    Abstract: The present application provides a human gene over-expressing animal, which is a non-human animal carrying a human hematopoietic prostaglandin D2 synthase gene in its somatic cell chromosome and expressing a large amount of human prostaglandin D2 synthase, wherein the animal is one obtained through ontogenesis of a totipotency cell of a non-human animal or offspring of the obtained animal, and the totipotency cell is introduced with said synthase gene. The present application also provides a method of using the transgenic animal for testing in vivo activity of a candidate for anti-allergy medicines, sleep-controlling substances and candidates for anti-obesity.
    Type: Grant
    Filed: October 5, 2000
    Date of Patent: April 10, 2007
    Assignees: Japan Science and Technology Corporation, Osaka Bioscience Institute, Oriental Yeast Co., Ltd.
    Inventors: Yoshihiro Urade, Yasushi Fujitani, Hiroaki Kitayama, Naoki Hayashi
  • Patent number: 7200291
    Abstract: Disclosed is a variable lightwave functional circuit comprising: an applying unit for applying lateral pressure; a polarization maintaining optical fiber having a polarization axis, for inducing a polarization mode coupling by applying the lateral pressure to a predetermined position by said applying unit; and a branching/coupling device having a first port to a fourth port, for branching laser light inputted from the first port to both said second port and said third port, and also for projecting laser light inputted from said second port to the fourth port; wherein one end of said polarization maintaining optical fiber is connected to one of said second port and said third port in such a manner that the polarization axis is inclined at a predetermined angle to an axial direction parallel to a branching plane of said branching/coupling device.
    Type: Grant
    Filed: May 24, 2006
    Date of Patent: April 3, 2007
    Assignee: Japan Science and Technology Corporation
    Inventor: Shinji Yamashita
  • Patent number: 7198701
    Abstract: To provide a method for analyzing a nucleic acid according to high throughput microcapillary electrophoresis during microchip electrophoresis under non-steady electric field, the method being capable of detecting polymorphism of a large number of genes at a high speed. The present invention is useful for the diagnosis and treatment of diseases such as detection of gene diseases and application to Taylor-made therapy.
    Type: Grant
    Filed: November 29, 2000
    Date of Patent: April 3, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Masanori Ueda, Hirohisa Abe, Yoshinobu Baba
  • Patent number: 7195698
    Abstract: An electrode plate of a sample plate is set on the body of an electrophoretic apparatus, while a plug is inserted into a migration high voltage line connection hole and connected to a high-tension distribution cable. Each well of a base plate is inserted into a through hole of a well guide and further press-fit and engaged into a cavity of an electrode plate, for fixing the base plate to the electrode plate. Thereafter a sample is introduced into each well of the base plate and an end of a capillary column is dipped into each well for applying a migration voltage and electrophoretically injecting the sample into the capillary column.
    Type: Grant
    Filed: December 13, 2002
    Date of Patent: March 27, 2007
    Assignees: The Institute of Physical and Chemical Research, Shimadzu Corporation, Japan Science and Technology Corporation
    Inventors: Yoshihide Hayashizaki, Shin Nakamura, Makoto Hazama, Hideshi Fujiwake
  • Patent number: 7195912
    Abstract: The thin film of the invention comprises a hydrate of a vitrified gel containing one or more extracellular matrix components, which can be integrated with a retainer as required. A hydrogel thin film containing one or more extracellular matrix components such as thin-film collagen hydrogel thin film, which is useful for a cell culture substratum and for preventing organ adhesion, can be easily prepared, and is excellent in expediency.
    Type: Grant
    Filed: January 18, 2005
    Date of Patent: March 27, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Toshiaki Takezawa, Katsutoshi Yoshizato
  • Patent number: 7193113
    Abstract: The present invention provides a method for producing various types of arylbis(perfluoroalkylsulfonyl)methane having a bulky aryl group and an electron-accepting aryl group in which synthesis was conventionally considered to be difficult, at high efficiency; a novel arylbis(perfluoroalkylsulfonyl)methane that can be widely applied to asymmertric catalyst, various types of functional materials and the like; and a metallic salt thereof. In addition, excellent catalysts are also provided. An aryl halomethane is reacted with a sodium trifluoromethane sulfinate, the arylmethyl triflone produced thereby is reacted with a t-BuLi and the like, the lithium salt of the arylmethyl triflone obtained is reacted with a trifluoromethane sulfonic acid anhydride, and an arylbis(trifluoromethylsulfony)methane such as pentafluorophenylbis(triflyl)methane, {4-(pentafluorophenyl)-2,3,5,6-tetrafluorophenyl}bis(triflyl)methane and the like are obtained at a high yield.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: March 20, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Kazuaki Ishihara, Hisashi Yamamoto
  • Patent number: 7192755
    Abstract: A nicotianamine synthase is isolated and purified. Then the gene of this enzyme is cloned and the base sequence and amino acid sequence thereof are determined. This gene is employed in constructing plants, in particular, grass plants highly tolerant to iron deficiency. A nicotianamine synthase involved in the mugineic acid biosynthesis pathway; the amino acid sequence thereof; a gene encoding the same; a vector containing this gene; cells transformed by the vector; a process for producing nicotianamine by using the same; plants transformed by the gene encoding the nicotianamine synthase; and an antibody against the nicotianamine syntase.
    Type: Grant
    Filed: April 30, 1999
    Date of Patent: March 20, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Satoshi Mori, Kyoko Higuchi, Kazuya Suzuki, Naoko Nishizawa, Hiromi Nakanishi
  • Patent number: 7186880
    Abstract: The present invention provides an adult T cell leukemia model animal, which is a T cell function deficient animal to which a cell line infected with human T cell leukemia virus-1 is transplanted. This model animal allows the HTLV-1 infected cell line to proliferate over a long period of time, and enables not only the tumorigenesis process but also the mechanism of onset of ATL and immune response mechanism of the host against ATL to be precisely analyzed.
    Type: Grant
    Filed: December 16, 2002
    Date of Patent: March 6, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Takashi Ohashi, Mari Kannagi
  • Patent number: 7183219
    Abstract: An SiO2 film layer formed at a wafer placed inside a process chamber of an etching device is etched by generating plasma from a process gas containing fluorocarbon which has been introduced into the process chamber. The contents of an etchant and the byproducts are measured through infrared laser absorption analysis. The individual contents thus measured are compared with the contents of the etchant and the byproducts in the plasma corresponding to the increase in the aspect ratio of a contact hole set in advance. The quantity of O2 added into the process gas is adjusted to match the measured contents with the predetermined contents. The quantity of O2 added into the process gas is continuously increased as the aspect ratio becomes higher. As a result, a contact hole is formed at the SiO2 film layer without damaging the photoresist film layer or inducing an etch stop.
    Type: Grant
    Filed: December 21, 1999
    Date of Patent: February 27, 2007
    Assignee: Tokyo Electron AT Limited and Japan Science and Technology Corporation
    Inventors: Kiichi Hama, Hiroyuki Ishihara, Akinori Kitamura
  • Patent number: 7169614
    Abstract: A convenient and commonly applicable method for the specific detection of a nucleic acid with an arbitrary sequence is provide. This method comprises attaching at least a nucleic acid single strand to an electrode, bringing the thus-obtained modified electrode in contact with a solution containing the analyte single-stranded nucleic acid, and measuring the redox reaction of the redox marker.
    Type: Grant
    Filed: March 13, 2001
    Date of Patent: January 30, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Yoshio Umezawa, Hiroshi Aoki
  • Patent number: 7166447
    Abstract: A probe for protein—protein interaction analysis suitable for analyzing protein—protein interactions of various proteins with high accuracy and in a simple manner and a method for analyzing interaction of two proteins by using the probe. With the probe, protein splicing is caused by protein—protein interaction, and a physicochemically or biochemically detectable protein is regenerated.
    Type: Grant
    Filed: December 27, 2000
    Date of Patent: January 23, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Yoshio Umezawa, Takeaki Ozawa
  • Patent number: 7166737
    Abstract: The present invention relates to a new manufacturing method for phosphonate esters, which have utility as a carbon-carbon binding formation agent, as well as a synthesis intermediate for biologically active substances such as medical drugs and agri-chemicals. Specifically the present invention relates to a new industrially advantageous manufacturing method for phosphonate esters in which the phosphonate esters of the subject can be efficiently obtained with a high yield rate through a simple operation while having barely any side reaction or sub-product. More specifically, the present invention pertains to a manufacturing method for phosphonate esters in which secondary phosphonate esters and alkene compounds are reacted in a transition metal catalyst. In addition the present invention relates to a new manufacturing method for allylphosphonate esters in which secondary cyclic phosphonate esters and 1,3-diene compounds are reacted in a palladium catalyst.
    Type: Grant
    Filed: May 26, 2004
    Date of Patent: January 23, 2007
    Assignees: Japan Science and Technology Corporation, National Institute of Advanced Industrial Science and Technology
    Inventors: Li-Biao Han, Farzad Mirzaei, Masato Tanaka
  • Patent number: 7166238
    Abstract: A novel liquid-crystalline ionic conductor, which is useful in the electric, electronic, chemical and bioengineering fields, as an anisotropic reaction solvent, ionic conductor, electric field-responsible conductor or the like, and a method for producing the same, is provided. The liquid-crystalline ionic conductor is obtained by mixing an organic molten salt with a-liquid-crystalline organic molecule or a liquid-crystalline inorganic molecule, which comprises a moiety miscible to the organic molten salt and a moiety that shows liquid-crystalline orientation, thereby forming a liquid-crystalline ionic conductor, wherein the organic molten salt is assembled to the liquid-crystalline molecule.
    Type: Grant
    Filed: September 14, 2005
    Date of Patent: January 23, 2007
    Assignee: Japan Science and Technology Corporation
    Inventors: Takashi Kato, Kiyoshi Kanie, Masafumi Yoshio, Hiroyuki Ohno, Masahiro Yoshizawa
  • Patent number: 7144376
    Abstract: A magnetic field distribution measurement device (1) provides a non-contact magnetic measurement on a subject's chest at a plurality of coordinates and forms therefrom time-series magnetic field distribution data. A first arithmetic device (2) in response generates image data representing a three-dimensional, intramyocardial current density distribution. A second arithmetic device (3) receives a plurality of tomographic image data separately obtained by a tomographic diagnosis apparatus and processes the data to generate three-dimensional, anatomical image data. A display device (4) receives these data and displays on an anatomical image an image representing an intramyocardial current density. Thus in a ventricle a lesioned or viable part of myocardium can be readily identified in location, size, geometry and level. Furthermore, the anatomical image may be replaced with an image representing a normal stimulation propagation circuit and serving as a template.
    Type: Grant
    Filed: July 17, 2001
    Date of Patent: December 5, 2006
    Assignees: Japan Science and Technology Corporation, Takenaka Corporation
    Inventors: Kenji Nakai, Masahito Yoshizawa, Kohei Kawazoe, Keita Yamazaki, Satoshi Fujita, Itsuro Tamura
  • Patent number: 7141435
    Abstract: An anti-NAIP monoclonal antibody recognizing a human apoptosis inhibitory protein NAIP having the amino acid sequence of SEQ ID NO: 1, which is produced from hybridoma prepared by fusing a myeloma cell line with antibody-producing cell of mammal immunized by antigen containing a polypeptide which comprises amino acid sequence of the 256–586th, the 841–1052nd or parts thereof in SEQ ID NO: 1, NAIP assay method using the antibody, and NAIP assay kits.
    Type: Grant
    Filed: November 1, 2002
    Date of Patent: November 28, 2006
    Assignees: Japan Science and Technology Corporation, Toyo Boseki Kabushiki Kaisya
    Inventors: Johe Ikeda, Harumi Sakai
  • Patent number: 7138494
    Abstract: Novel sodium-independent small neutral amino acid transporters which transport L- and D-amino acids. A protein comprising the amino acid sequence represented by SEQ ID NO:1 or 4 or an amino acid derived therefrom by deletion, substitution or addition of one or more amino acids and being capable of sodium-independently transporting L- and D-small neutral amino acids and analogs thereof; a gene encoding the above protein; a method of screening substances inhibiting or promoting the function of the above protein; an antibody against the above protein; and a method of regulating cell function by using the above antibody, function inhibitors, function promoters, etc.
    Type: Grant
    Filed: August 7, 2002
    Date of Patent: November 21, 2006
    Assignee: Japan Science and Technology Corporation
    Inventors: Hitoshi Endou, Yoshikatsu Kanai
  • Patent number: 7135583
    Abstract: A novel process for preparation of alkenylphosphine oxides or alkenylphosphinic acid esters provided by which the objective compounds can be easily, safely and efficiently synthesized and easily separated and purified with little formation of by-products. Specifically, a process of conducting the addition reaction of an easily available secondary phosphine oxide or hydrogen phosphinic acid ester with an acetylene compound with a catalyst containing a Group 9 or 10 metal of the periodic table to thereby obtain the corresponding alkenylphosphine oxide or alkenylphosphinic acid ester.
    Type: Grant
    Filed: February 12, 2002
    Date of Patent: November 14, 2006
    Assignees: Japan Science and Technology Corporation, National Institute of Advanced Industrial Science & Technology
    Inventors: Li-biao Han, Chang-qiu Zhao, Masato Tanaka
  • Publication number: 20060248617
    Abstract: It is intended to provide an efficient and sure gene targeting method embodied at an arbitrary position in the genome of an organism and a kit therefor. It is also intended to provide a method for targeted-disruption of an arbitrary gene in the genome of an organism which comprises: 1) the step of providing the whole sequencial data of the genome of the organism; 2) the step of selecting at least one arbitrary region in the sequence; 3) the step of providing a vector containing a sequence homologous with the region selected above and a marker gene; 4) the step of transforming the organism by the vector; and 5) the step of providing the organism under such conditions as allowing homologous recombination. Moreover, the genome of a hyperthermostable bacterium and its array are provided.
    Type: Application
    Filed: August 29, 2003
    Publication date: November 2, 2006
    Applicant: Japan Science and Technology Corporation
    Inventors: Tadayuki Imanaka, Haruyuki Atomi